Skip to main content
OpenTrials
Completed

NCT Number: NCT00286884

Heart Rate Variability in White Coat Hypertension and Essential Hypertension

The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Medical Research, Holstebro Hospital

Holstebro, 7500, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 30-70 years
  • office BP >150/95 mmHg and 24-h ambulatory BP =/>135/85 mmHg
  • office BP >150/95 mmHg and 24-h ambulatory BP <135/85 mmHg
  • office BP <150/95 mmHg and 24-h ambulatory BP <135/85 mmHg

Exclusion criteria

  • Clinical signs of disease of the heart, lungs, liver, kidneys, brain or endocrine organs
  • neoplastic disease
  • daily use of medicine
  • alcohol abuse
  • abnormal laboratory screening including blood-hemoglobin, blood-white cell count, plasma-creatinine, plasma-alanine-amino-transaminases, plasma-albumin, plasma-sodium, plasma-potassium, urinary glucose, urinary albumin; electrocardiogram
  • pregnancy
  • unwillingness to participate

Treatment and study plan

Monitoring of heart rate variability

Procedure

Sponsors and collaborators

Lead sponsor

Regional Hospital Holstebro

Other

Registry information

Important dates

First posted
Feb 6, 2006
Registry last updated
Sep 11, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.